US 10308720
Multivalent and multispecific DR5-binding fusion proteins
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 10308720 (Multivalent and multispecific DR5-binding fusion proteins) held by Inhibrx, Inc. expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inhibrx, Inc.
- Grant date
- Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61P, A61P35/00